Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Psyence Group Inc.
  6. Company
    PSYG   CA74449Q1063

PSYENCE GROUP INC.

(PSYG)
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  05/20 03:31:40 pm EDT
0.0650 CAD   -13.33%
04/19Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products
MT
04/19Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products
AQ
02/25Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
CI
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
Psyence Group Inc is a Canada-based company, which provides science-led global psychedelic platform. The Company builds and operates commercial psilocybin cultivation and production facilities. It is pioneering the use of natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences.
Managers
Name Title Age Since
Neil Maresky, Dr. Chief Executive Officer - 2021
Warwick Corden-Lloyd Chief Financial Officer 41 2021
Justin Grant Chief Scientific Officer - 2021
Michael Dacks Chief Operating Officer 44 2020
Lisa-Marie Iannitelli Head-Investor Relations - -
Tony Budden Chief Strategy Officer - -
Taryn Vos General Counsel - 2021
Members of the board
Name Title Age Since
Jody Aufrichtig Executive Chairman 47 2021
Gavin Basserabie Independent Director 50 2021
Marvin Joseph Singer Independent Director 69 2021
Alan Friedman Director 49 2021
Muhamad Amza Ali, Dr. Director 59 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 85,528,931 74,745,791 87.4% 0 0.0% 87.4%
Shareholders
NameEquities%
Glen van Kerkvoort 2,978,039 3.48%
Alan Friedman 2,601,460 3.04%
Muhamad Amza Ali 2,487,283 2.91%
Jody Aufrichtig 1,742,434 2.04%
Marvin Joseph Singer 212,998 0.25%
Warwick Corden-Lloyd 175,593 0.21%
Neil Maresky 92,600 0.11%
Fisher Asset Management LLC 0 -
Boys, Arnold & Co., Inc. 0 -
Parsec Financial Management, Inc. 0 -
Brand Portfolio
In partnership withAllbrands.markets
More brands of Psyence Group Inc.
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
PSYENCE GROUP INC.-58.33%4
MODERNA, INC.-46.35%54 195
LONZA GROUP AG-27.84%41 796
IQVIA HOLDINGS INC.-28.46%38 202
SEAGEN INC.-9.68%25 704
ICON PUBLIC LIMITED COMPANY-30.22%17 567
ALNYLAM PHARMACEUTICALS, INC.-23.72%15 980
CELLTRION, INC.-26.77%15 744
BIO-TECHNE CORPORATION-29.19%14 373
PHARMARON BEIJING CO., LTD.-19.46%12 721
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.-38.26%11 819
HANGZHOU TIGERMED CONSULTING CO., LTD-30.35%11 109
QIAGEN N.V.-20.03%10 297
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.3.06%10 090
UNITED THERAPEUTICS CORPORATION-12.84%8 531
SYNEOS HEALTH, INC.-30.94%7 274
GENSCRIPT BIOTECH CORPORATION-35.22%5 991
IONIS PHARMACEUTICALS, INC.29.77%5 600
BACHEM HOLDING AG0.00%5 458
AZENTA, INC.-31.86%5 182
JOINN LABORATORIES (CHINA) CO.,LTD.-16.62%5 063
Connections : Psyence Group Inc.